1
|
Coêlho CFF, Souza ILS, Chagas VT, Ribeiro NLX, Pinto BAS, França LM, Paes AMDA. Myricetin improves metabolic outcomes but not cognitive deficit associated to metabolic syndrome in male mice. Food Funct 2021; 12:3586-3596. [PMID: 33900338 DOI: 10.1039/d1fo00073j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Myricetin is a flavonol highly prevalent in edible vegetables and fruits, with recognized hypoglycemic and anti-obesity effects, besides great antioxidant capacity. Thus, this study sought to investigate whether myricetin is able to improve metabolic and behavioral outcomes found in monosodium l-glutamate (MSG) obese mice, a model of metabolic syndrome characterized by early hyperinsulinemia associated to obesity, dyslipidemia, hepatic steatosis, anxiety and cognitive deficit. Newborn male mice received MSG (4 mg kg-1 day-1, s.c.) on alternate days during the first 10 days of life for obesity induction, while control pups received equimolar saline solution. From postnatal day 90 to 135, MSG mice were orally treated with myricetin (50 mg kg-1 day-1) or distilled water, while control animals received vehicle. During the last week of treatment, all groups were submitted to behavioral tests: open field maze, elevated plus maze and Morris water maze. At the end of treatment, animals were euthanized for collection of liver, serum and adipose tissue fat pads. Myricetin treatment reduced the elevated serum levels of glucose and triglycerides, typically found in MSG mice, as well as restored peripheral insulin sensitivity and liver steatosis. Moreover, myricetin ameliorated the lack of thigmotaxis and exploratory behavior, but did not improve the cognitive deficit presented by MSG mice. Therefore, this study contributes to the pharmacological validation of myricetin as an affordable and healthy therapeutic adjuvant for the treatment of metabolic syndrome and most of its comorbidities.
Collapse
Affiliation(s)
- Caio Fernando Ferreira Coêlho
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil.
| | - Ivana Letícia Santos Souza
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil.
| | - Vinicyus Teles Chagas
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil. and Department of Morphological Sciences, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil
| | - Nathalee Liberal Xavier Ribeiro
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil.
| | - Bruno Araújo Serra Pinto
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil. and Department of Physiological Sciences, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil
| | - Lucas Martins França
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil. and Department of Physiological Sciences, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil
| | - Antonio Marcus de Andrade Paes
- Laboratory of Experimental Physiology, Health Sciences Graduate Program, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil. and Department of Physiological Sciences, Federal University of Maranhão, 1966, São Luís, MA 65080-805, Brazil
| |
Collapse
|
2
|
Morris MJ, Tortelli CF, Filippis A, Proietto J. Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. REGULATORY PEPTIDES 1998; 75-76:441-7. [PMID: 9802441 DOI: 10.1016/s0167-0115(98)00100-1] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Neuropeptide Y (NPY) exerts effects on food intake at the level of the paraventricular nucleus (PVN), which receives a dense projection from the arcuate nucleus. Monosodium glutamate (MSG) has been shown to induce hyperadiposity despite hypophagia associated with chemical ablation of the arcuate nucleus. We investigated the mechanism for the excess fat accumulation by studying the time course of changes in brain NPY content, food intake, leptin levels and BAT GLUT4 content after neonatal MSG treatment. Male rat pups were injected with MSG or saline vehicle on days 2, 4, and 6 and examined at 30 and 90 days. Plasma leptin, body mass, length, adipose tissue mass and brown fat GLUT4 were measured and brains dissected for measurement of NPY content. By 30 days, NPY concentrations were reduced in the arcuate nucleus and anterior hypothalamus, and animals tended to be hypophagic. Peripheral adipose tissue levels were less than controls, in line with their low leptin concentrations. At 90 days, MSG treatment was associated with marked reductions in NPY concentrations in several hypothalamic areas, including the PVN and arcuate nucleus, along with increased adiposity and plasma leptin. Animals also displayed marked hypophagia. Levels of GLUT4 transporter were reduced in brown adipose tissue at both ages. The early decrease in brown fat GLUT4 suggests an impairment of the hypothalamic sympathetic input to brown fat which disrupts thermogenesis, contributing to the development of adiposity in the presence of hypophagia.
Collapse
Affiliation(s)
- M J Morris
- Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.
| | | | | | | |
Collapse
|
3
|
Abstract
Increased body temperature (fever or hyperthermia) is a physiological response to many different stimuli. In fact, fever (a 1-4°C elevation of the body temperature) is not only a clinical symptom common to many infectious diseases but also a side effect of immunostimulating or antiviral therapies. Hyperthermic reactions, on the other hand, can be observed after treatment with antipsychotic drugs, 5-hydroxytryptamine-receptor agonists, and acetylcholinesterase inhibitors and as a reaction to anesthesia. Moreover, hyperthermic reactions can be related to particularly stressful emotional states, to the menstrual ovulatory cycle, and to pregnancy. Transient hyperthermia or fever is also a common consequence of cerebral ischemic events, and it is present during stress as well as intense physical exercise. This review focuses on fever, one of the main components of the systemic acute-phase reaction to external proinflammatory stimuli. Special emphasis is given to neuronal mechanisms of fever induction, in which the hypothalamus plays a crucial role in both control of the febrile response as well as other centrally mediated neurological signs of inflammation, such as increased sleep, activation of the hypothalamic-pituitary-adrenal axis, anorexia, and sickness behavior. This review pays particular attention to the role of proinflammatory cytokines as endogenous pyrogens. NEUROSCIENTIST 4:113-121, 1998
Collapse
Affiliation(s)
- Anna K. Sundgren-Andersson
- Department of Neurochemistry and Neurotoxicology (AKS-A), Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden, Research (SG), Pharmacia and UpJohn, S.p.A., Nerviano, Italy, Department PharmaResearch Preclinical Nervous System (TB), F. Hoffmann-La Roche, Ltd., Basel, Switzerland
| | - Silvia Gatti
- Department of Neurochemistry and Neurotoxicology (AKS-A), Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden, Research (SG), Pharmacia and UpJohn, S.p.A., Nerviano, Italy, Department PharmaResearch Preclinical Nervous System (TB), F. Hoffmann-La Roche, Ltd., Basel, Switzerland
| | - Tamas Bartfai
- Department of Neurochemistry and Neurotoxicology (AKS-A), Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden, Research (SG), Pharmacia and UpJohn, S.p.A., Nerviano, Italy, Department PharmaResearch Preclinical Nervous System (TB), F. Hoffmann-La Roche, Ltd., Basel, Switzerland
| |
Collapse
|
4
|
Scallet AC, Ye X. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann N Y Acad Sci 1997; 825:194-205. [PMID: 9369987 DOI: 10.1111/j.1749-6632.1997.tb48429.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Endogenous excitatory amino acids (EAAs) such as glutamic or aspartic acids have been proposed to mediate the brain damage to EAA receptor-rich brain sites that is caused by a variety of external toxic agents (glutamic acid, domoic acid, kainic acid, ibogaine, trimethyltin (TMT), 3-nitropropionic acid (3-NPA)), as well as from such naturally-occurring age-related neurodegenerative diseases as Alzheimer's disease, Huntington's chorea, and Parkinson's disease. Sites often damaged include the hypothalamus (glutamate), the hippocampal and neocortical pyramidal neurons (domoic acid), the cerebellar Purkinje neurons (ibogaine) and the corpus striatum (3-NPA, amphetamine). The excitotoxic damage occurs to neuronal cell bodies and their dendrites, resulting in a characteristics appearance of pyknotic neurons surrounded by their vacuolated, swollen dendrites. Axons passing through the region that lack EAA receptors are completely spared. However, astrocytes with swollen perikarya and nuclei (Alzheimer's type II "reactive" astrocytes) are often observed in the vicinity of the lesions. Animal and human "Prion Diseases" or "Transmissible Spongiform Encephalopathies" (TSEs) result (after a period of months to years) in a neurodegenerative picture characterized by pyknotic neurons surrounded by vacuoles with numerous reactive astrocytes in the vicinity of the damage. In addition, amyloid deposits composed of a protease-resistant protein (PrPSc) characteristic of the particular host species with the disease are found near the degenerating neurons. By using different strains of the scrapies TSE agent to inoculate hamsters and mice, reproducible models of hypothalamic, hippocampal, or cerebellar damage resulting in the appropriate functional deficits may be obtained. Because of the close similarity in the appearance, localization, and functional consequences from TSE neuropathology compared to some of the well-known EAA syndromes, we propose that excitotoxic mechanisms may play a role in the pathogenesis of TSE neurodegenerative diseases. The similarity in pathogenesis of the neurodegenerative processes in excitotoxicity compared to TSE diseases also implies that neuroprotective strategies against excitotoxicity may also be effective against TSEs.
Collapse
Affiliation(s)
- A C Scallet
- Division of Neurotoxicology, Food and Drug Administration, Jefferson, Arkansas 72079-9502, USA.
| | | |
Collapse
|
5
|
Dawson R, Simpkins JW, Wallace DR. Age- and dose-dependent effects of neonatal monosodium glutamate (MSG) administration to female rats. Neurotoxicol Teratol 1989; 11:331-7. [PMID: 2796887 DOI: 10.1016/0892-0362(89)90003-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The age- and dose-dependent effects of neonatal MSG were evaluated in pre- and postpubertal female rats. The neurotoxic action of MSG was assessed by examining monoamine content in microdissected regions of the mediobasal hypothalamus. MSG was administered at a dose of 4 mg/g on postnatal days 2 and 4 (MSG-Lo) or on postnatal days 2, 4, 6 and 8 (MSG-Hi). MSG-Hi treatment significantly reduced dopamine (DA) content in the arcuate nucleus (ANH) and lateral median eminence (LME) on postnatal day 21 when compared to NaCl-injected controls. DA content relative to controls was not altered in the ANH or LME postnatal or postnatal day 60 in MSG-Hi, however, norepinephrine (NE) was significantly (p less than 0.05) decreased on both postnatal day 21 and 60 in the LME. MSG-Lo treatment significantly (p less than 0.05) reduced ANH NE content on postnatal day 60 compared to controls. Both MSG-Hi and MSG-Lo treatment increased 5-hydroxyindoleacetic acid content in the preoptic area (POA) on postnatal day 60 relative to the controls. Developmental changes independent of MSG treatment were noted in the hypothalamus. DA and 3,4-dihydroxyphenylacetic acid (DOPAC) content in the POA were 2-3-fold higher on postnatal day 21 compared to postnatal day 60. In contrast, DA content increased with age in the ANH, LME and medial ME. NE content in the ANH increased as a function of age in controls, but not in MSG-treated rats. The effects of MSG treatment on the postnatal development and maturation of neurons in the mediobasal hypothalamus were discussed in relation to the direct neurotoxicity of MSG.
Collapse
Affiliation(s)
- R Dawson
- Department of Pharmacodynamics, University of Florida, College of Pharmacy JHMHC, Gainesville 32610
| | | | | |
Collapse
|
6
|
Abstract
Monosodium-L-Glutamate (MSG) produces lesions to monoaminergic and peptidergic neurons in several brain areas. The present study examined the effect of neonatal MSG treatment on oxytocin (OXY), arginine-vasopressin (AVP) and somatostatin (SRIF) concentrations in several discrete brain areas of adult rats. OXY increased in the suprachiasmatic and arcuate nuclei and median eminence (ME) and decreased in the paraventricular nucleus of MSG-treated rats. MSG treatment caused AVP to increase in the arcuate nucleus and ME and decrease in the supraoptic nucleus. SRIF decreased following neonatal MSG treatment in both the ME and neurointermediate pituitary lobe. The results demonstrate that the effects of neonatal MSG treatment on neuropeptide content are not just limited to the arcuate nucleus. Furthermore, taken together with previous results, the data suggest that these changes may be indicative of functional deficits in the neuronal activity of some of these peptidergic neurons which, in turn, may be responsible for the abnormal secretion of several pituitary hormones observed in MSG-treated animals.
Collapse
|
7
|
Tesone M, Ladenheim RG, Charreau EH. Alterations in the prolactin secretion in streptozotocin-induced diabetic rats. Correlation with pituitary and hypothalamus estradiol receptors. Mol Cell Endocrinol 1985; 43:135-40. [PMID: 3935499 DOI: 10.1016/0303-7207(85)90076-0] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The present study examined the effects of streptozotocin-induced diabetes on prolactin (Prl) secretion and its correlation with estrogen receptor levels in the anterior pituitary and hypothalamus. Prl was measured in adult ovariectomized rats and after estradiol treatment (10 micrograms estradiol benzoate (Eb) 48, 24 and 1 h before experiments) or acute TRH administration (4 micrograms/kg body weight). Substantial decreases in estradiol- and TRH-induced Prl release were observed in diabetic rats. Insulin therapy was able to restore this response. Measurement of nuclear estradiol receptors by exchange assay in the pituitary of Eb-treated rats revealed a significant reduction in receptor levels in the diabetic group and a restoration to normal values in insulin-treated diabetic rats. Similar results were obtained by measuring total pituitary receptor content (cytosolic plus nuclear receptors). No significant changes were observed in nuclear hypothalamic estradiol receptors. However, the number of total hypothalamic estradiol receptors was diminished in diabetic rats although the translocation was proportionally greater in these animals. These results indicate that the disrupted reproductive functions described in streptozotocin diabetic rats may be due, at least in part, to deficiencies in Prl secretion and pituitary estradiol action.
Collapse
|
8
|
Johnston CA, Spinedi EJ, Negro-Vilar A. Effects of neonatal monosodium glutamate (MSG) treatment on the hormonal and central monoaminergic dynamics associated with acute ether stress in the male rat. Brain Res Bull 1984; 13:643-9. [PMID: 6097343 DOI: 10.1016/0361-9230(84)90196-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Neonatal treatment with monosodium glutamate (MSG) induces severe neurochemical damage to several brain regions, and these lesions are expressed in adult life by a variety of endocrine and behavioral abnormalities. The present study analyzes the extent of the neurochemical damage to several monoaminergic systems by evaluating the changes in norepinephrine (NE), dopamine (DA), and 5-hydroxytryptamine (5-HT) metabolism induced by the neurotoxin in several discrete hypothalamic loci. Moreover, the study also evaluated the ability of MSG-treated rats to respond to acute ether stress, by measuring the release of ACTH and prolactin induced by ether and correlating those changes with the alterations in monoamine metabolism in the arcuate (AN), dorsomedial (DMN), and suprachiasmatic (SCN) nuclei and in the median eminence (ME). The results indicate that MSG treatment induces marked changes in monoamine metabolism in several of the regions examined. The metabolite of DA, dihydroxyphenylacetic acid, was markedly depressed in the AN, SCN, and DMN. NE metabolism was also significantly lower in the AN of MSG-treated animals. 5-HT metabolism was also altered by MSG treatment, with significant decrements recorded in the SCN, DMN, and AN. Both control and MSG-treated rats showed highly significant increments in ACTH and PRL release 5 and 15 min after exposure to ether vapors. The only quantitative difference between the two groups was a smaller increment in ACTH levels 5 min after ether in the MSG group. Ether stress increased DA metabolism in the AN, NE metabolism in the AN and DMN, and 5-HT metabolism in the SCN in control animals.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
|